Literature DB >> 34511959

Characteristics of Grade 2 Disability in Indonesian Children with Leprosy: A Five-Year Multicenter Retrospective Study.

Hendra Gunawan1,2,3, Atika Kamilia1,2, Sri Linuwih Menaldi2,3,4, Melani Marissa2,4, Cita Rosita Sigit Prakoeswa2,3,5, Medhi Denisa Alinda2,5, Dhelya Widasmara2,6, Santosa Basuki2,6, Qaira Anum2,7, Tutty Ariani2,7, Enricco H Mamuaja2,8, Luh Made Mas Rusyati2,9.   

Abstract

BACKGROUND: One of the indicators of achieved leprosy control is lower new cases of leprosy with grade 2 disability (G2D), while zero new pediatric case with G2D is one of the targets of The Global Leprosy Strategy. This study aimed to describe the characteristics of leprosy in children with G2D from seven provincial hospitals in Indonesia, spanning a period of five years.
METHODS: This was a descriptive and retrospective study with cross-sectional design. Data were obtained from the medical records of leprosy-affected children in seven provincial hospitals in Indonesia between January 2014 and December 2019 using a total sampling method. Data obtained include characteristics of patients, clinical manifestations, and profile of leprosy in children with G2D.
RESULTS: From the 132 data of childhood leprosy retrieved, male (58.33%), age group of 13-14 years (47.73%), and borderline tuberculoid leprosy (34.09%) comprised the majority of patients. Most of the patients had anesthetic macules as the initial manifestation. The results showed 20 (15.15%) children had G2D. Hands were the most common site affected (50.00%), manifested as claw hands, contractures, atrophy of thenar and hypothenar muscles, and pseudomutilation. Foot drop was seen in five (62.50%) children, and lagophthalmos was seen in one child with leprosy.
CONCLUSION: This study shows that G2D is observed in 15.15% Indonesian children with leprosy at the time of diagnosis, which mostly occurs on the hands in the form of claw hands. Foot disabilities were also observed, most commonly as foot drop, while lagophthalmos was present with disabilities in the eyes. Disability due to leprosy in children really exists. The commitment of all health care services and related institutions is needed in order to reduce the incidence of disability due to leprosy in children.
© 2021 Gunawan et al.

Entities:  

Keywords:  children; grade 2 disability; leprosy

Year:  2021        PMID: 34511959      PMCID: PMC8420076          DOI: 10.2147/CCID.S325858

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


Introduction

Leprosy is an infectious disease that remains a major health problem in developing countries, including Indonesia.1,2 Nerve damage that occurs in leprosy can develop into disabilities and create stigma in the society.3 In endemic areas, leprosy in children aged less than 15 years is common. The incidence of leprosy in children can be an indicator of the disease’s prevalence in the general population and is associated with an active source of transmission.4 In 2020, the World Health Organization (WHO) reported 202.185 new leprosy cases registered globally from 127 countries, corresponding to a prevalence of 0.2 per 10,000, with 14.981 (7.40%) cases occurring in children. One of the targets of The Global Leprosy Strategy is zero new cases of leprosy in children with grade 2 disability (G2D). According to the 2020 WHO data, there were 10,813 new cases of leprosy with G2D, with 370 (3.42%) of these occurring in children.5 Clinical symptoms of leprosy in children are sometimes atypical.4 This may cause delay in diagnosis, that can lead to disability and reduced the quality of life.6 Epidemiological data regarding the characteristics of disability in children with leprosy are limited. Therefore, this retrospective study aims to describe the characteristics of leprosy in children with G2D from seven provincial hospitals in Indonesia in the course of five years.

Methods

A cross-sectional descriptive and retrospective study was conducted on medical records of leprosy-affected children in Dermatology and Venereology Clinic of seven provincial hospitals in Indonesia. Data regarding childhood leprosy registered between January 2014 and December 2019 were collected using total sampling method. This study was approved by Hasan Sadikin Hospital Ethics Committee Number LB.02.01/X.6.5/172/2020 and conducted in accordance with the latest version of the Declaration of Helsinki. The need for informed consent was waived by the Institutional Review Board as the study was non-interventional and the secondary patient’s data provide were sufficiently anonymized. Descriptive analysis was performed on the data of patient characteristics, clinical manifestations, and profile of leprosy in children with G2D including age, sex, leprosy type based on Ridley-Jopling classification, initial symptoms, leprosy reaction, presence of neuritis, bacterial index, the status of treatment, the type of treatment, the degree and type of disability. Disability in leprosy is defined by the WHO grading system: Grade 0−absence of disability (no anesthesia) and no visible damage or deformity on eyes, hands, or feet; Grade 1−loss of protective sensibility on eyes, hands, and feet; Grade 2−presence of deformities or visible damage to the eyes, hands, or feet.7

Results

A total of 132 cases were diagnosed as new cases of leprosy in children in the 5-year study period. Seventy-seven (58.33%) patients were male and 55 were female (41.67%). The highest prevalence occurred in the age group of 13–14 years old (47.73%). Only one case found in less than 4 years old age group. The distribution of age and gender of leprosy patients in children is presented in Table 1.
Table 1

Characteristics of Childhood Leprosy Patients

CharacteristicsTotal Childhood Leprosy Patients
Frequency (n=132)Percentage (%)
GenderMale7758.33
Female5541.67
Age< 4 years old10.76
4–6 years old64.55
7–9 years old2418.18
10–12 years old3828.79
13–14 years old6347.73
Leprosy typeTT96.82
BT4534.09
BB2518.94
BL3929.55
LL1410.61
Initial manifestationHypopigmented macule12292.42
Nodule107.58
ReactionRR2720.45
ENL139.85
None9269.70
NeuritisYes1712.88
No11587.12
BINegative6750.76
1+ or 2+2015.15
3+ or 4+2518.94
5+ or 6+10.76
Not tested1914.39
Therapy statusOngoing3728.03
RFT9571.97
Type of therapyMDT-PB5440.91
MDT-MB7859.09

Abbreviations: TT, tuberculoid; BT, borderline tuberculoid; BB, borderline borderline; BL, borderline lepromatous; LL, lepromatous leprosy; RR, reversal reaction; ENL, erythema nodosum leprosum; BI, bacterial index; RFT, released from treatment; MDT, multidrug therapy; PB, paucibacillary; MB, multibacillary.

Characteristics of Childhood Leprosy Patients Abbreviations: TT, tuberculoid; BT, borderline tuberculoid; BB, borderline borderline; BL, borderline lepromatous; LL, lepromatous leprosy; RR, reversal reaction; ENL, erythema nodosum leprosum; BI, bacterial index; RFT, released from treatment; MDT, multidrug therapy; PB, paucibacillary; MB, multibacillary. Based on the type of leprosy by Ridley-Jopling classification, borderline tuberculoid leprosy comprised the majority of the patients (34.09%). Most of the patients (94.42%) had anesthetic macules as their initial manifestation, while 7.58% patients had nodules. Twenty-seven patients (20.45%) developed a reversal reaction and 13 (9.85%) patients had history of erythema nodosum leprosum (ENL). Neuritis was found in 17 patients (12.88%). The percentage of cases was slightly higher on negative bacterial index (BI) (50.76%) than on positive BI (34.85%), while 14.39% of the patients were not tested. On treatment status, most patients were eventually released from treatment (71.97%). The majority of patients (59.09%) received multidrug therapy for multibacillary leprosy (MDT-MB). Clinical characteristics of leprosy patients in children are summarized in Table 1. A total of 34 (25.76%) children with leprosy had disabilities, with 14 (10.61%) being grade 1 disability (G1D) and 20 (15.15%) being G2D. The grade of disability in children is presented in Table 2. Among the children with G2D, hand disabilities (50.00%) were the most common. The location of disability in childhood leprosy patient is presented in Table 2. Four (40.00%) patients had claw hands, three (30.00%) patients showed contractures, two (20.00%) patients had atrophy of the thenar and hypothenar muscles, and one (10.00%) patient had pseudomutilation. Among eight (6.07%) patients with foot disabilities, it was noted that five (62.50%) patients had foot drop and three (37.50%) patients had ulcer. Eye disability, manifesting as lagophthalmos, was present in one patient. The type of disability is summarized in Table 3.
Table 2

Grade and Location of Disability in Childhood Leprosy Patients

CharacteristicsTotal Cases
Frequency (n=132)(%)
Grade of disability09874.24
11410.61
22015.15
Location of disability
EyesGrade 013098.48
Grade 100
Grade 221.52
HandGrade 012090.90
Grade 121.52
Grade 2107.58
FootGrade 012393.18
Grade 110.75
Grade 286.07
Table 3

Types of Grade 2 Disability of the Hand, Foot, and Eye in Childhood Leprosy Patients

CharacteristicsFrequency (n)Percentage (%)
Grade 2 Disability of the Hand (n=10)
 Claw hand430.00
 Contracture540.00
 Atrophy of thenar and hypothenar muscle220.00
 Pseudomutilation110.00
 Ulcer00
Grade 2 Disability of the Foot (n=8)
 Foot drop562.50
 Ulcer367.50
 Contracture00
 Atrophy of the thenar and hypothenar muscle00
 Pseudomutilation00
Grade 2 Disability of the Eyes (n=2)
 Lagophthalmos150
Grade and Location of Disability in Childhood Leprosy Patients Types of Grade 2 Disability of the Hand, Foot, and Eye in Childhood Leprosy Patients

Discussion

According to the 2020 WHO leprosy data, there were 17,439 new cases in Indonesia, with 2009 cases occurred in children.5 Our study was conducted from 2014 to 2019 and included 132 new childhood cases of leprosy. The incidence of leprosy in children can be an indicator of the disease’s prevalence in the general population and is associated with the existence of an active source of transmission. Childhood leprosy is usually transmitted from family contacts, indicating the high disease transmissibility in the community.4 Our study showed that the highest proportion of cases were found in the age group of 13–14 years old (47.73%), followed by 10–12 years old (28.79%), and 7–9 years old (18.18%). This result was similar to a study by Darlong et al in India, which showed the most prevalent case of leprosy in children occurred in the age group of 13–15 years old.6 In a study by Rodrigues et al in Brazil, the highest proportion of cases occurred among those aged 8–14 years old.8 In another study by Zia et al in Pakistan, the most affected age group was 11–14 years old.9 This distribution shows that leprosy is more common in adolescents (older children), which may be due to the disease’s relatively long incubation period.10 According to data from the Ministry of Health of the Republic of Indonesia in 2018, new cases of leprosy in Indonesia were more prevalent in males (9,872 cases) compared to females (6,048 cases).2 In the current study, leprosy was also most commonly found in males than in females. Similar results were found in other studies by Darlong et al in India, Santos et al in Brazil, Ramos et al in Ethiopia, and Jha et al in Nepal.6,11–13 This might be due to involved environmental and socio-cultural factors such as greater exposure from more outdoor activities in males.10 Cultural factor may also play a role, where parents of male children were less likely to seek medical attention compared to parents of female children.4 Our study showed that borderline tuberculoid leprosy (34.09%) was the most common type of leprosy seen in children. Similiar result was found in a study by Kumaravel et al. That reported BT as the most common leprosy type in children (58.70%).10 The study by Ramos et al reported that the most common type of leprosy in patients aged ≤18 years was the MB type.12 Although the majority of leprosy in children under 15 years of age in India were paucibacillary (PB), a study by Pinto et al found that MB cases were predominant.14 The high number of children with MB leprosy may be related to the delay in reporting,15 widespread nerve damage, and extensive nerve involvement.13 In the current study, the majority of childhood leprosy patients had early symptoms of hypopigmented anesthetic macules on the skin (92.42%), while 10 patients (7.58%) had nodules as their early symptom. This was similar with other studies by Zia et al9 in Pakistan, Narang et al16 in India, and Das et al17 in India, who found that the most common initial symptom in childhood leprosy patients was anesthetic hypopigmented macules on exposed body parts, such as the face, arms, and lower limbs. Leprosy reactions are a major cause of nerve damage and morbidity in leprosy patients.12 There are two types of leprosy reaction: type 1 reaction (reversal reaction) and type 2 reaction (ENL).12 In this study, leprosy reaction occurred as type 1 in 14 (10.61%) patients and type 2 in 20 (15.15%) patients. The clinical manifestation of leprosy depends on the interaction between M. leprae and the immune response.3 The results of several other studies showed that the frequency of leprosy reactions in children tends to be low.13,15,16 Cases of leprosy reaction in children range from 3.1% to 33.9% compared to adults, which can be as high as 50%.14 In this study, neuritis was found in 17 (12.88%) patients. Govindharaj et al in their study showed that neuritis in pediatric leprosy was relatively uncommon (18.5%).15 The finding of leprosy reaction and/or neuritis in this study revealed the severity of the cases and may cause neural damage and deformities. This condition should be identified and treated immediately and adequately to prevent disabilities. The majority of patients in the current study were released from therapy (71.97%). This was similar to another study by Govindharaj et al,15 who reported that the majority of leprosy patients observed in that study completed their therapy. This data is crucial to the effort of preventing disabilities in pediatric leprosy patients and also for the attention of health planners to the need to develop health system and special actions for childhood in leprosy. Children with disability have many difficulties in education, social life, and daily activities.16 In this study, G2D was found in 20 cases. From the results of a study in India, it was known that in children aged less than 14 years, a disability from leprosy was uncommon. G1D was only found in 3% of cases, and G2D was found in 5% cases.18 In the current study, G2D of the hands occurred in 10 (50.00%) cases, in the form of claw hands (40.00%), contractures (30.00%), atrophy of the thenar and hypothenar muscles (20.00%), and pseudomutilation (10.00%). G2D of the foot occurred in 8 patients, which manifested as foot drop (62.50%) and ulcer (37.50%). Disabilities of the eyes occurred as lagophthalmos in one patient. Kumaravel et al10 in their study found that the most common disability in pediatric leprosy cases was claw hand, followed by tropic ulcers, foot drop, and wrist drop. The high incidence of claw hand is due to the fact that the ulnar nerve is the most commonly affected peripheral nerve. Paralytic deformities are caused by the destruction of motor nerve fibers innervating the intrinsic and motor muscles. Overall, disabilities in childhood leprosy were often caused by ignorance of the child’s family, lack of cooperation, and delay in diagnosis and therapy, resulting in disease progression that may lead to disability.6

Conclusion

This study shows that G2D is observed in 15.15% Indonesian children with leprosy at the time of diagnosis, which mostly occurs on the hands in the form of claw hands. Foot disabilities were also observed, most commonly as foot drop, while lagophthalmos was present with disabilities in the eyes. Disability due to leprosy in children really exists, indicating active transmission and delays in diagnosis and treatment of leprosy. The commitment of all health care services and related institutions is needed in order to reduce the incidence of disability due to leprosy in children.
  8 in total

1.  Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.

Authors: 
Journal:  Lepr Rev       Date:  2006-09       Impact factor: 0.537

2.  Children and adolescents' attitude towards having leprosy in a high endemic district of India.

Authors:  Pitchaimani Govindharaj; Joydeepa Darlong; Annamma S John; Suresh Mani
Journal:  Lepr Rev       Date:  2016-03       Impact factor: 0.537

3.  Leprosy and disability in children younger than 15 years in an endemic area of northeast Brazil.

Authors:  Victor S Santos; Lilian C Santos; Laís V R Lôbo; Lígia M D Lemos; Ricardo Q Gurgel; Luis E Cuevas
Journal:  Pediatr Infect Dis J       Date:  2015-03       Impact factor: 2.129

4.  Leprosy with ulnar nerve abscess: ultrasound findings in a child.

Authors:  Helena Barbosa Lugão; Marco Andrey Cipriani Frade; Nilton Mazzer; Norma Tiraboschi Foss; Marcello Henrique Nogueira-Barbosa
Journal:  Skeletal Radiol       Date:  2016-10-27       Impact factor: 2.199

5.  Epidemiological and Clinical Characteristics of Children and Adolescents with Leprosy Admitted Over 16 Years at a Rural Hospital in Ethiopia: A Retrospective Analysis.

Authors:  José M Ramos; Sonia Ortiz-Martínez; Deriba Lemma; Matheus M Petros; Carmen Ortiz-Martínez; Abraham Tesfamariam; Francisco Reyes; Isabel Belinchón
Journal:  J Trop Pediatr       Date:  2018-06-01       Impact factor: 1.165

6.  Profiles of Pediatric Leprosy: A Report from a University Hospital of Nepal in the Post-Elimination Era.

Authors:  Rumit Jha; Suchana Marahatta
Journal:  Am J Trop Med Hyg       Date:  2021-01       Impact factor: 3.707

7.  Profile of leprosy in children under 15 years of age monitored in a Brazilian referral center (2004-2012).

Authors:  Ana Cecília Versiani Duarte Pinto; Patrick Alexander Wachholz; Gardenia Viana da Silva; Paula Yoshiko Masuda
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

8.  Factors associated with leprosy in children contacts of notified adults in an endemic region of Midwest Brazil.

Authors:  Thaísa S V Rodrigues; Luciane C Gomes; Denise C B Cortela; Eliane A Silva; Cristiane A L Silva; Silvana M B Ferreira
Journal:  J Pediatr (Rio J)       Date:  2019-06-07       Impact factor: 2.990

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.